Ymab investors have opportunity to lead y-mabs therapeutics, inc. securities fraud lawsuit

Los angeles , feb. 3, 2023 /prnewswire/ -- the law offices of frank r. cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against y-mabs therapeutics, inc. ("y-mabs" or the "company") (nasdaq: ymab).

YMAB Ratings Summary

YMAB Quant Ranking